Absci Corp (ABSI) Stock Price, Quote & News

Company Profile

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 360 949 1041

Website: www.absci.com

Address:

18105 SE Mill Plain Boulevard, Vancouver, United States

Maxim89 Sep. 15 at 8:25 PM

$ABSI This company will be worth $100 billion by 2030. Edge cutting drug discovery through AI, powered with AMD GPUs and Oracle AI infrastructure

0 · Reply

Maxim89 Sep. 15 at 8:07 PM

0 · Reply

Baddb Sep. 15 at 6:23 PM

$ABSI can’t wait till earnings the hype gonna be real this is early entry boyz ✌️

1 · Reply

NETpositive Sep. 15 at 5:44 PM

$ABSI this is usually a good sign for SP

1 · Reply

cristiraj Sep. 15 at 12:18 PM

$ABSI news are here! going up 40%?

0 · Reply

BiotechInvestor94 Sep. 15 at 5:53 AM

$RXRX $ABCL on further note I think i like $ABSI more. AMD and Oracle partnership is huge plus their lead candidate is TL1A. Something I have personally worked at work designing IC50 TR-FRET assays for it and DR3 + DcR3

0 · Reply

Bullbear1010101 Sep. 13 at 11:18 PM

$ABSI ipo price action told the story

0 · Reply

The300 Sep. 13 at 3:45 PM

$ABSI ok, so despite a 15% pop following a fake press release about “collaborating” Oracle, proce is down 1% on the week. net result: credibility damaged for no benefit results speak louder than word please, already, show is what AI can actually do!

0 · Reply

MomentumDetector Sep. 12 at 8:28 PM

$BHAT $ABSI $NAKA $XPEV :

0 · Reply

Chant2023 Sep. 12 at 8:16 PM

$ABSI is this a glitch in the matrix or what 🤷‍♂️

0 · Reply

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

AMD ORCL

Sep 11, 2025, 8:00 AM EDT - 4 days ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 9, 2025, 12:13 AM EDT - 6 days ago

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 25, 2025, 4:05 PM EDT - 21 days ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 20, 2025, 8:00 AM EDT - 26 days ago

Absci to Participate in Upcoming Investor Conferences

Aug 13, 2025, 12:25 AM EDT - 4 weeks ago

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 4 weeks ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 7, 2025, 2:00 AM EDT - 5 weeks ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Jul 30, 2025, 4:05 PM EDT - 6 weeks ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 25, 2025, 8:34 AM EDT - 7 weeks ago

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

ASTS INTC

Jul 24, 2025, 8:45 PM EDT - 7 weeks ago

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 7 weeks ago

Absci Announces Proposed Public Offering of Common Stock

Jul 7, 2025, 8:00 AM EDT - 2 months ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

May 13, 2025, 10:45 PM EDT - 4 months ago

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:05 PM EDT - 4 months ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:01 PM EDT - 4 months ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Apr 14, 2025, 4:05 PM EDT - 5 months ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 3, 2025, 3:15 PM EDT - 5 months ago

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Mar 19, 2025, 8:15 AM EDT - 6 months ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HQY TNXP

Mar 18, 2025, 7:37 PM EDT - 6 months ago

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:05 PM EDT - 6 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 4, 2025, 4:05 PM EST - 6 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:00 PM EST - 6 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 4, 2025, 8:00 AM EST - 6 months ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Feb 18, 2025, 8:00 AM EST - 7 months ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Jan 22, 2025, 1:22 PM EST - 8 months ago

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

AMD

Jan 22, 2025, 8:00 AM EST - 8 months ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 13, 2025, 2:05 AM EST - 8 months ago

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

AMD

Jan 10, 2025, 7:30 AM EST - 8 months ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 8 months ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 6, 2025, 8:00 AM EST - 9 months ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Nov 12, 2024, 10:01 AM EST - 10 months ago

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 7:30 AM EST - 10 months ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 7, 2024, 8:00 AM EST - 11 months ago

Absci to Host R&D Day on December 12, 2024

Oct 15, 2024, 8:00 AM EDT - 11 months ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 3, 2024, 12:36 PM EDT - 1 year ago

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Aug 16, 2024, 11:50 PM EDT - 1 year ago

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Jul 28, 2024, 1:24 AM EDT - 1 year ago

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

May 28, 2024, 8:00 AM EDT - 1 year ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 14, 2024, 1:30 PM EDT - 1 year ago

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

May 14, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 1, 2024, 4:01 PM EST - 1 year ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Feb 21, 2024, 7:30 AM EST - 1 year ago

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Jan 10, 2024, 7:30 AM EST - 1 year ago

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Jan 3, 2024, 8:00 AM EST - 1 year ago

Absci to Participate in the 26th Annual Needham Growth Conference

Dec 28, 2023, 8:00 AM EST - 1 year ago

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Maxim89 Sep. 15 at 8:25 PM

$ABSI This company will be worth $100 billion by 2030. Edge cutting drug discovery through AI, powered with AMD GPUs and Oracle AI infrastructure

0 · Reply

Maxim89 Sep. 15 at 8:07 PM

0 · Reply

Baddb Sep. 15 at 6:23 PM

$ABSI can’t wait till earnings the hype gonna be real this is early entry boyz ✌️

1 · Reply

NETpositive Sep. 15 at 5:44 PM

$ABSI this is usually a good sign for SP

1 · Reply

cristiraj Sep. 15 at 12:18 PM

$ABSI news are here! going up 40%?

0 · Reply

BiotechInvestor94 Sep. 15 at 5:53 AM

0 · Reply

Bullbear1010101 Sep. 13 at 11:18 PM

$ABSI ipo price action told the story

0 · Reply

The300 Sep. 13 at 3:45 PM

0 · Reply

MomentumDetector Sep. 12 at 8:28 PM

$BHAT $ABSI $NAKA $XPEV :

0 · Reply

Chant2023 Sep. 12 at 8:16 PM

$ABSI is this a glitch in the matrix or what 🤷‍♂️

0 · Reply

musky54 Sep. 12 at 8:01 PM

$ABSI crazy

0 · Reply

N0_Brainers Sep. 12 at 5:14 PM

$ABSI bought more. Let’s go.

0 · Reply

Trexxxxxxxx Sep. 12 at 4:55 PM

$ABSI i bought rxrx the other day instead of absi. It worked out ok but i like the recent news here so i grabbed some at 2.60

0 · Reply

7m3835d3 Sep. 12 at 4:51 PM

$ABSI No need to panic, biotech is down today. We will still see two major catalysts in 2025 - partnership with at least one large pharma company and ABS-101 safety/PK

0 · Reply

hideonbush1 Sep. 12 at 4:49 PM

$ABSI lets sell this and buy $OPEN

1 · Reply

GasLeTrader Sep. 12 at 4:39 PM

$ABSI How is this low? How is this undiscovered ?

0 · Reply

karwan3005 Sep. 12 at 3:43 PM

$ABSI is a golden stock and will start to take off very soon.

0 · Reply

Rach8672 Sep. 12 at 2:28 PM

$ABSI why would this be down

0 · Reply

CasperPuff Sep. 12 at 2:17 PM

$ABSI love that I get to buy in early.

1 · Reply

prismmarketview Sep. 12 at 1:23 PM

(NASDAQ: $ABSI) Absci partners with Oracle + AMD to turbocharge AI-driven drug discovery. Leveraging OCI + MI355X GPUs, the collab aims to cut costs + speed biologics design cycles. #Biotech #AI #DrugDiscovery https://prismmarketview.com/absci-accelerates-ai-driven-biologics-discovery-with-oracle-and-amd/

0 · Reply

I_am_stonky Sep. 12 at 1:18 PM

$ABSI moving

0 · Reply

Baddb Sep. 12 at 1:14 PM

$ABSI could get interesting

0 · Reply

Market Cap	381.28M
Revenue (ttm)	4.53M
Net Income (ttm)	-103.11M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,276.16%
Debt to Equity Ratio	0.01

Volume	3,626,600
Avg Vol	5,354,888
Day's Range	N/A - N/A
Shares Out	149.52M
Stochastic %K	40%
Beta	2.01
Analysts	Strong Sell
Price Target	$8.74